🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Université Catholique de Louvain clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Belgium and Switzerland registers with Université Catholique de Louvain as lead sponsor. Synced 28 Sep 2026
42Current trials
29Recruiting now
1Drug in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Université Catholique de Louvain is the lead sponsor of 42 current clinical trials in our Belgium and Switzerland registers. 29 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Arterial blood sample. The most-studied condition is Healthy.

ClinicalTrials.gov trials by status

  • Recruiting2969%
  • Not yet open717%
  • Active, closed37%
  • By invitation37%

Trials by phase

  • Not applicable2457%
  • Observational1843%
01

Clinical trials sponsored by Université Catholique de Louvain

42 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Study of E. Coli Isolates From Recurrent Urinary Tract Infections
NCT05826067 · ClinicalTrials.gov ↗ · Urinary Tract Infections, Patients With Suprabubic Catheter, Patients With Nephrostomy Catheter
Observational Recruiting 2023-04 Belgium
Birth Experience of Women Giving Birth in Belgium
NCT07263971 · ClinicalTrials.gov ↗ · Pregnancy Related
Observational Recruiting 2025-09 Belgium
Prediction of Tongue Base Obstruction During Sleep
NCT06792045 · ClinicalTrials.gov ↗ · Obstructive Sleep Disordered Breathing
Observational Recruiting 2025-08 Belgium
Impact of Omega 3 in Alcohol Use Disorder
NCT05899660 · ClinicalTrials.gov ↗ · Alcohol Use Disorder, Severe
Not applicable Recruiting 2023-06 Belgium
Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA)
NCT05900778 · ClinicalTrials.gov ↗ · Acquired Brain Injury
Not applicable Recruiting 2023-06 Belgium
Gait Control in Parkinson Disease
NCT05908279 · ClinicalTrials.gov ↗ · Parkinson Disease
Observational Recruiting 2023-05 Belgium
CKD Cachexia and Gut Microbiome
NCT06986265 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, Cachexia
Observational Recruiting 2025-02 Belgium
Assessment of a New Tool to Measure Tongue Muscle Function
NCT07625761 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-06 Belgium
Tongue Protrusion Assessment in Healthy Adult (FLEPI)
NCT06169761 · ClinicalTrials.gov ↗ · Healthy
Observational Recruiting 2023-12 Belgium
Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke
NCT05727111 · ClinicalTrials.gov ↗ · Stroke
Not applicable Recruiting 2023-05 Belgium
Flexible Reaching Control in Parkinson Disease
NCT05908266 · ClinicalTrials.gov ↗ · Parkinson Disease
Observational Recruiting 2023-05 Belgium
CAP48 - Autism in Children and Adolescents
NCT06149468 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder
Observational Recruiting 2023-09 Belgium
Collaborative Clinical Reasoning: Perceptions and Practices of General Practitioners, Physical Therapists, and Patients With Low Back Pain in Primary Care
NCT07802951 · ClinicalTrials.gov ↗ · Collaborative Clinical Reasoning
Not applicable Recruiting 2026-09 Belgium
Effects of Respiratory Muscle Training on Tongue Muscle Function
NCT06627283 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2024-11 Belgium, Switzerland
Study of Lipid Mediators in Chronic Postoperative Pain - LICP
NCT06907810 · ClinicalTrials.gov ↗ · Breast Cancer Female, Postoperative Pain
Not applicable Recruiting 2025-03 Belgium
Implementation of a HABIT-ILE Intervention at Home for Children With Bilateral Cerebral Palsy
NCT05740605 · ClinicalTrials.gov ↗ · Cerebral Palsy
Not applicable Recruiting 2023-02 Belgium
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916 · ClinicalTrials.gov ↗ · Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Psoriatic Arthritis
Observational Recruiting 2013-09 Belgium
Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With Obesity
NCT07402031 · ClinicalTrials.gov ↗ · Obesity & Overweight
Observational Recruiting 2026-05 Belgium
Autonomous At Home with Occupational Therapy Support and Assistive Devices
NCT06819982 · ClinicalTrials.gov ↗ · Frailty, Aging, Home Care Services
Not applicable Recruiting 2024-03 Belgium
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
NCT06373822 · ClinicalTrials.gov ↗ · Adenomyosis
Observational Recruiting 2024-03 Belgium
Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm
NCT07590986 · ClinicalTrials.gov ↗ · Myeloproliferative Neoplasm (MPN), Polycytemia Vera, Essential Thrombocythemia (ET)
Observational Recruiting 2026-05 Belgium
Acute Effects of Post-Exercise Hyperoxia on Recovery in Cycling
NCT07659301 · ClinicalTrials.gov ↗ · Athletic Performance, Hyperbaric Oxygenation, Physical Endurance
Not applicable Recruiting 2026-07 Belgium
Tongue Muscular Assessment in Healthy Children
NCT06166680 · ClinicalTrials.gov ↗ · Healthy
Observational Recruiting 2023-10 Belgium
Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort
NCT07420231 · ClinicalTrials.gov ↗ · Intestinal Discomfort, Abdominal Pain/ Discomfort
Not applicable Recruiting 2026-03 Belgium
Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders
NCT06997354 · ClinicalTrials.gov ↗ · Children Suffering From Cortical Visual Impairment
Observational Recruiting 2025-04 Belgium
WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer
NCT07142096 · ClinicalTrials.gov ↗ · Breast Cancer
Not applicable Recruiting 2025-07 Belgium
Assessing Chronic Pain Patient Preferences
NCT07453524 · ClinicalTrials.gov ↗ · Chronic Pain
Not applicable Recruiting 2026-03 Belgium
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
NCT07384897 · ClinicalTrials.gov ↗ · Lung Cancer (Diagnosis), Sarcoidosis, Chronic Obstructive Pulmonary Disease
Not applicable Recruiting 2025-02 Belgium
EUmetriosis: Insights Into the Pathogenesis of Endometriosis
NCT07000786 · ClinicalTrials.gov ↗ · Endometriosis
Not applicable Recruiting 2025-05 Belgium
Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA) - Adult
NCT06931795 · ClinicalTrials.gov ↗ · Stroke
Not applicable Not yet open 2025-04 Belgium
Change in Platelet Lipid Metabolism and Procoagulant Phenotype Induced by Cardiopulmonary Bypass. Impact on Postoperative Inflammatory Response and Bleeding Complications During Cardiac Surgery.
NCT07630987 · ClinicalTrials.gov ↗ · Cardiac Surgery, Cardiopulmonary Bypass, Platelet Activation
Not applicable Not yet open 2026-05 Belgium
The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclerosis and Response to Treatment
NCT07788573 · ClinicalTrials.gov ↗ · Multiple Sclerosis
Observational Not yet open 2026-08 Belgium
A Geriatric Mobile Team for Nursing Home Residents: a Feasibility Pilot Study
NCT06873919 · ClinicalTrials.gov ↗ · Nursing Home Resident, Geriatric Assessment
Observational Not yet open 2025-03 Belgium
Assessment of GARP Expression in Acute and Chronic Coronary Syndrome
NCT07384910 · ClinicalTrials.gov ↗ · Atheroma; Heart
Not applicable Not yet open 2026-02 Belgium
Assessment of Platelet-derived GARP in Atherosclerotic Disease
NCT07364058 · ClinicalTrials.gov ↗ · Atheroma; Carotid Artery, Atheromatosis
Observational Not yet open 2026-02 Belgium
Effects of HABIT-ILE in Adults with Bilateral Cerebral Palsy
NCT06767930 · ClinicalTrials.gov ↗ · Cerebral Palsy, Bilateral Cerebral Palsy
Not applicable Not yet open 2025-01 Belgium
Bridging the Gap: Implementing BRIDGES
NCT07422909 · ClinicalTrials.gov ↗ · Inactive People, Depression
Not applicable By invitation 2026-03 Belgium
ADHAirE : a Randomized Controlled Trial to Improve the Implementation of Tobacco-free School Policies
NCT06655038 · ClinicalTrials.gov ↗ · Smoking, Adolescent Behavior
Not applicable By invitation 2024-04 Belgium
Sex-difference in Response to Resistance Exercise and Training
NCT07692815 · ClinicalTrials.gov ↗ · Male, Female, Healthy Adult
Not applicable By invitation 2026-02 Belgium
Study of Children's Well-being After the COVID-19 Pandemic in Belgian French-speaking Primary Schools
NCT05747638 · ClinicalTrials.gov ↗ · Well-being
Observational Active, closed 2023-03 Belgium
Factors Determining the Rate of Adoption of Pharmaceutical Recommendations by Patients in Primary Care Following a Medication Review by a Pharmacist
NCT07606716 · ClinicalTrials.gov ↗ · Polypharmacy (People Under Treatment With 5 or More Drugs), Polypharmacy, Decision-making, Medication Review
Not applicable Active, closed 2026-01 Belgium
Phenotypic and Genotypic Characterization of New-onset Type I Diabetes
NCT04007809 · ClinicalTrials.gov ↗ · Type1diabetes
Not applicable Active, closed 2019-06 Belgium

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Université Catholique de Louvain trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Université Catholique de Louvain trials

66 conditions
Healthy4Stroke2Parkinson Disease2Cerebral Palsy2Inactive People1Depression1Urinary Tract Infections1Patients With Suprabubic Catheter1Patients With Nephrostomy Catheter1Pregnancy Related1Obstructive Sleep Disordered Breathing1Alcohol Use Disorder, Severe1Cardiac Surgery1Cardiopulmonary Bypass1Platelet Activation1Acquired Brain Injury1Multiple Sclerosis1Chronic Kidney Diseases1Cachexia1Autism Spectrum Disorder1Collaborative Clinical Reasoning1Breast Cancer Female1Postoperative Pain1Well-being1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Belgium4229
Clinical trials in Switzerland11

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Healthy

SponsorTrials
Eli Lilly and Company17
Merck Sharp & Dohme15
Boehringer Ingelheim14
Pfizer10
University of Electronic Science and Technology of China10
University of Copenhagen7
Centre Hospitalier Universitaire de Saint Etienne6
Olly, PBC5
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences4
The Hospital for Sick Children4

Sponsors with the most current trials registered for this condition.

06

Questions about Université Catholique de Louvain trials

How many clinical trials does Université Catholique de Louvain sponsor?

Université Catholique de Louvain is the lead sponsor of 42 current trials on ClinicalTrials.gov in our Belgium and Switzerland registers, as of the registry sync on 28 September 2026. Completed and withdrawn studies are not counted.

Are Université Catholique de Louvain trials recruiting?

Yes. 29 of its 42 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Université Catholique de Louvain testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Arterial blood sample (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 28 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.